Notícias

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the best NASDAQ stocks with high upside potential. On May 28, Intuitive announced the promotion of Taylor Patton to Chief Commercial and Marketing Officer, effective July 1. Patton, who has spent nearly two decades at the company, previously led the global endoluminal business, including the successful launch of […]

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Is PRCT a good stock to buy? We came across a bullish thesis on PROCEPT BioRobotics Corporation on r/ValueInvesting by mrmrmrj. In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT BioRobotics Corporation’s share was trading at $20.91 as of June 17th. Procept BioRobotics (PRCT) is a high-growth surgical robotics company with rapid revenue scaling […]

Intuitive Surgical (NASDAQ:ISRG) is positioned for multi-decade compounding because it sits at the center of an aging-world healthcare megatrend with a razor-and-blade business model that compounds quietly whether the broader market is euphoric or fearful. The case for permanence rests on three pillars, and none of them depend on a single quarter, a single product ... 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 50 Years

Medtronic is deeply undervalued and a good bet for your portfolio. At the time, an uncertain growth outlook kept us from recommending the stock. Four months later, it’s time to retire the narrative of Medtronic as a perpetual laggard.

Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

While Align Technology has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $416.55, marking a +1.34% move from the previous day.

Investors need to pay close attention to (Ticker) stock based on the movements in the options market lately.

ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.

The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

FDA safety alerts and voluntary recalls tied to Intuitive Surgical stapler reloads have brought fresh regulatory focus to the da Vinci platform. The issues relate to certain da Vinci S and Si instruments and SureForm reloads, with complaints prompting added scrutiny from regulators. Investors have reacted, with NasdaqGS:ISRG down 26.9% year to date and 19.7% over the past year, and the stock last closing at $411.06. This mix of regulatory pressure and weaker recent returns is putting...

Mastercard, Seagate and Intuitive Surgical lead Zacks' featured reports as AI demand, payments growth and procedure expansion shape outlooks.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Mastercard, Seagate and Intuitive Surgical headline new research reports, highlighting growth drivers, outlooks and key challenges shaping performance.

Is ISRG a good stock to buy? We came across a bullish thesis on Intuitive Surgical, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on ISRG. Intuitive Surgical, Inc.’s share was trading at $412.02 as of June 10th. ISRG’s trailing and forward P/E were 50.06 and 39.68 respectively according to Yahoo […]

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $426.61, indicating a +1.91% shift from the previous trading day.

Intuitive Surgical’s fair value estimate has been reset from US$611.82 to US$565.25, signaling a lower price target that analysts are now using in their models. This shift lines up with recent research that blends optimism about the company’s long term growth potential with caution around weaker medtech sentiment and a reset in sector valuations, leaving opinions on the stock’s risk reward profile divided. As you read on, you will see how this evolving narrative may shape how you track...

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.

Over the long term, the IHI ETF looks like a good turnaround story.

Medtronic wants a bite of the robotics-assisted surgery market, which could swell to over $63 billion over the next decade.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

If you are wondering whether Intuitive Surgical at around US$418.82 is starting to look attractively priced or still expensive, it helps to break the story into what the stock has done recently and how that lines up with its fundamentals. The share price is down 1.1% over the past week, 7.2% over the past month, and 25.5% year to date, although it is still up 34.7% over three years and 46.2% over five years. These mixed returns sit against an ongoing stream of interest in robotic assisted...

Intuitive Surgical (ISRG) is back in focus after promoting Taylor Patton to Chief Commercial and Marketing Officer. This leadership shift puts commercial execution, global scaling, and its surgical data and AI ambitions under the spotlight for investors. See our latest analysis for Intuitive Surgical. The stock has fallen 25.5% year to date on a share price basis and is down 25.0% over the past year on a total shareholder return basis, signaling fading momentum despite a 46.3% total...

These stocks are down more than 10% this year, and now could be a great time to buy them for the long haul.

The robotic-surgery leader has lost nearly a third of its value since January. Here's what's weighing on the stock.

Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.

Although Becton, Dickinson and Company has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

Intuitive Surgical, Inc. (ISRG) reached $407.29 at the closing of the latest trading day, reflecting a +1.24% change compared to its last close.